X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with Divis Laboratories - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs DIVIS LABORATORIES - Comparison Results

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA DIVIS LABORATORIES SHASUN PHARMA/
DIVIS LABORATORIES
 
P/E (TTM) x 123.9 31.3 395.4% View Chart
P/BV x 8.5 5.4 157.2% View Chart
Dividend Yield % 0.2 0.9 25.5%  

Financials

 SHASUN PHARMA   DIVIS LABORATORIES
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
DIVIS LABORATORIES
Mar-17
SHASUN PHARMA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs941,222 7.7%   
Low Rs46784 5.8%   
Sales per share (Unadj.) Rs214.2153.1 139.9%  
Earnings per share (Unadj.) Rs5.339.9 13.4%  
Cash flow per share (Unadj.) Rs15.844.6 35.5%  
Dividends per share (Unadj.) Rs1.0010.00 10.0%  
Dividend yield (eoy) %1.41.0 143.5%  
Book value per share (Unadj.) Rs53.3201.8 26.4%  
Shares outstanding (eoy) m56.62265.47 21.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.36.6 5.0%   
Avg P/E ratio x13.125.1 52.2%  
P/CF ratio (eoy) x4.422.5 19.6%  
Price / Book Value ratio x1.35.0 26.4%  
Dividend payout %18.725.0 74.9%   
Avg Mkt Cap Rs m3,958266,266 1.5%   
No. of employees `000NA9.7 0.0%   
Total wages/salary Rs m2,1644,687 46.2%   
Avg. sales/employee Rs ThNM4,175.0-  
Avg. wages/employee Rs ThNM481.5-  
Avg. net profit/employee Rs ThNM1,089.3-  
INCOME DATA
Net Sales Rs m12,12740,643 29.8%  
Other income Rs m229749 30.6%   
Total revenues Rs m12,35641,392 29.9%   
Gross profit Rs m1,00914,460 7.0%  
Depreciation Rs m5941,233 48.1%   
Interest Rs m41523 1,836.7%   
Profit before tax Rs m23013,953 1.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-733,349 -2.2%   
Profit after tax Rs m30210,604 2.8%  
Gross profit margin %8.335.6 23.4%  
Effective tax rate %-31.724.0 -131.9%   
Net profit margin %2.526.1 9.5%  
BALANCE SHEET DATA
Current assets Rs m6,88440,105 17.2%   
Current liabilities Rs m8,4566,595 128.2%   
Net working cap to sales %-13.082.5 -15.7%  
Current ratio x0.86.1 13.4%  
Inventory Days Days62119 52.0%  
Debtors Days Days10881 133.3%  
Net fixed assets Rs m4,97019,995 24.9%   
Share capital Rs m113531 21.3%   
"Free" reserves Rs m2,87553,043 5.4%   
Net worth Rs m3,02053,574 5.6%   
Long term debt Rs m1,8170-   
Total assets Rs m13,34761,585 21.7%  
Interest coverage x1.6618.4 0.3%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.90.7 137.7%   
Return on assets %5.417.3 31.1%  
Return on equity %10.019.8 50.5%  
Return on capital %13.326.1 51.1%  
Exports to sales %46.40-   
Imports to sales %14.225.2 56.4%   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,72810,259 16.8%   
Fx inflow Rs m5,84335,384 16.5%   
Fx outflow Rs m2,17310,399 20.9%   
Net fx Rs m3,66924,985 14.7%   
CASH FLOW
From Operations Rs m39811,493 3.5%  
From Investments Rs m-1,635-11,372 14.4%  
From Financial Activity Rs m1,309-93 -1,405.6%  
Net Cashflow Rs m7128 250.7%  

Share Holding

Indian Promoters % 39.2 52.0 75.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 11.8 30.5%  
FIIs % 17.6 19.0 92.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 17.2 230.2%  
Shareholders   20,750 31,796 65.3%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  CADILA HEALTHCARE  GSK PHARMA  PANACEA BIOTECH  

Compare SHASUN PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - PLETHICO PHARMA COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS